运动终止慢波睡眠-一个潜在的生物标志物?
Yvonne Höller1, Stefanía Guðrún Eyjólfsdóttir1, Matej Rusiňák1,2
1Faculty of Psychology, University of Akureyri, 600 Akureyri, Iceland.
Brain sciences
|May 25, 2024
概括
身体运动结束慢波睡眠 (SWS) 情节的频率更高,SWS持续时间更长. 一小组服用塞特拉林的患者没有显示SWS运动终止,这表明药物对睡眠连续性的潜在影响.
科学领域:
- 神经科学是一个神经科学.
- 睡眠医学 睡眠医学
背景情况:
- 慢波睡眠 (SWS) 持续时间会影响睡眠质量和整体健康.
- 终止SWS事件的内部线索尚未得到充分理解.
- 通过睡眠脑电图 (EEG) 通过肌电图 (EMG) 检测到的身体运动可能标志着SWS终止.
研究的目的:
- 调查SWS通过运动终止作为潜在的生物标志物.
- 描述SWS运动终止与各种个人和临床因素之间的关系.
主要方法:
- 来自视频EEG监控单元的94个全夜EEG-EMG记录的分析.
- 对EEG和EMG记录进行视觉检查,以识别由运动结束的SWS事件.
- 多重线性回归用于根据年龄,性别,SWS持续时间/光谱,时间型,抑郁症,药物,记忆表现和特征来预测SWS运动终止.
主要成果:
- 较长的SWS总体持续时间与较多的SWS发作以运动结束的次数显著相关 (t = 5.64; p = 0.001).
- 没有其他测试的变量,包括相关的因素,显示与SWS运动终止有显著的关系.
- 服用塞特拉林的小部分样本 (n=4) 没有出现SWS运动终止,与其他患者和未服用药物的患者显著不同 (p < 0.001).
结论:
- 运动终止性SWS的持续时间是影响运动终止性SWS发作的一个关键因素.
- 这些发现表明,SWS运动终止可能作为睡眠连续性的生物标志物.
- 塞特拉林观察到的效果需要在更大的队列中进行进一步的研究,以确认其对睡眠和药物效应的影响.
相关概念视频
01:24Sleep-Wake Cycles
1.3K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.3K
01:22Stages of Sleep
184
Sleep progresses through distinct stages, each characterized by specific brain wave patterns and physiological responses ranging from wakefulness to stages of non-rapid eye movement, known as non-REM, to rapid eye movement, referred to as REM. Understanding these stages helps in recognizing how sleep supports various bodily and cognitive functions.
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
184
01:15REM Sleep Behavior Disorder
181
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
181
01:17Sleepwalking and Sleep Talking
153
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
153
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170
01:19Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244